BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15161587)

  • 1. Role of gene expression arrays in sarcomas.
    Skubitz KM; Skubitz AP
    Curr Oncol Rep; 2004 Jul; 6(4):309-14. PubMed ID: 15161587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of sarcomas using bioinformatics and molecular profiling.
    Dang TA; Man TK
    Curr Pharm Biotechnol; 2007 Apr; 8(2):83-91. PubMed ID: 17430156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis of sarcomas.
    Nielsen TO
    Adv Anat Pathol; 2006 Jul; 13(4):166-73. PubMed ID: 16858150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of sarcomas: new vistas for precision medicine.
    Al-Zaid T; Wang WL; Somaiah N; Lazar AJ
    Virchows Arch; 2017 Aug; 471(2):243-255. PubMed ID: 28664413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences from tissue microarray in soft tissue sarcomas.
    Nilbert M; Engellau J
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):29-34. PubMed ID: 15188663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics.
    Segal NH; Pavlidis P; Antonescu CR; Maki RG; Noble WS; DeSantis D; Woodruff JM; Lewis JJ; Brennan MF; Houghton AN; Cordon-Cardo C
    Am J Pathol; 2003 Aug; 163(2):691-700. PubMed ID: 12875988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
    van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
    PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-expression profiling to classify soft-tissue sarcomas.
    Dirix LY; van Oosterom AT
    Lancet; 2002 Apr; 359(9314):1263-4. PubMed ID: 11965266
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling in sarcomas.
    Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels RD
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):111-24. PubMed ID: 17555981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers.
    Fujiwara T; Kunisada T; Takeda K; Uotani K; Yoshida A; Ochiya T; Ozaki T
    Biomed Res Int; 2014; 2014():592868. PubMed ID: 25165708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance.
    Konstantinopoulos PA; Fountzilas E; Goldsmith JD; Bhasin M; Pillay K; Francoeur N; Libermann TA; Gebhardt MC; Spentzos D
    PLoS One; 2010 Apr; 5(4):e9747. PubMed ID: 20368975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cDNA microarray analysis of global gene expression in sarcomas.
    Schofield D; Triche TJ
    Curr Opin Oncol; 2002 Jul; 14(4):406-11. PubMed ID: 12130925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust gene expression signature is not merely a significant P value.
    Brulard C; Chibon F
    Eur J Cancer; 2013 Aug; 49(12):2771-3. PubMed ID: 23664094
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA microarrays in pediatric cancer.
    Triche TJ; Schofield D; Buckley J
    Cancer J; 2001; 7(1):2-15. PubMed ID: 11269644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNAs and Soft Tissue Sarcomas.
    Fujiwara T; Kunisada T; Takeda K; Ozaki T
    Adv Exp Med Biol; 2015; 889():179-99. PubMed ID: 26659002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method.
    Takahashi H; Nemoto T; Yoshida T; Honda H; Hasegawa T
    BMC Bioinformatics; 2006 Sep; 7():399. PubMed ID: 16948864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA profiling of primary high-grade soft tissue sarcomas.
    Renner M; Czwan E; Hartmann W; Penzel R; Brors B; Eils R; Wardelmann E; Büttner R; Lichter P; Schirmacher P; Mechtersheimer G
    Genes Chromosomes Cancer; 2012 Nov; 51(11):982-96. PubMed ID: 22811003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.